The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the impact of perioperative antibiotic prophylaxis on the microbiome in patients with cutaneous malignancy.
 
Samuel Cass
No Relationships to Disclose
 
Russell G. Witt
No Relationships to Disclose
 
Xialong Meng
No Relationships to Disclose
 
Pranoti Sahasrabhojane
No Relationships to Disclose
 
Roland L. Bassett
No Relationships to Disclose
 
Samuel Shelburne
Research Funding - Accelerate Diagnostics
 
Hsiu Yin Chang
No Relationships to Disclose
 
Kinjal Somaiya
No Relationships to Disclose
 
Kristi Mungovan
No Relationships to Disclose
 
Sarah B. Fisher
No Relationships to Disclose
 
Anthony Lucci
Speakers' Bureau - Exact Sciences
 
Jeffrey Edwin Lee
No Relationships to Disclose
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Novartis; Novartis; Regeneron; Syndax
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Sheila Duncan
No Relationships to Disclose
 
Nadim J. Ajami
Stock and Other Ownership Interests - Moderna Therapeutics
Research Funding - SNIPR BIOME
 
Christina Lynn Roland
Research Funding - Bristol-Myers Squibb
 
Jennifer Ann Wargo
Stock and Other Ownership Interests - Micronoma
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Dava Oncology; Genentech; Gilead Sciences; GlaxoSmithKline; Illumina; Merck; Novartis; Society for Immunotherapy of Cancer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Illumina; Merck; Novartis
Speakers' Bureau - Dava Oncology; Genentech; Illumina; Novartis; PER; Precision Health Economics; Precision Health Economics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent submitted regarding the role of the microbiome in response to immune checkpoint blockade
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dava Oncology; Genentech; GlaxoSmithKline; Illumina; Novartis
 
Emily Zhi-Yun Keung
No Relationships to Disclose